The estimated Net Worth of Kevin C Knightly is at least $27.2 million dollars as of 28 February 2024. Mr. Knightly owns over 13,206 units of IQVIA Inc stock worth over $3,288,503 and over the last 8 years he sold IQV stock worth over $21,272,590. In addition, he makes $2,613,750 as President - Information and Technology Solutions at IQVIA Inc.
Sign up
Mr. Knightly IQV stock SEC Form 4 insiders trading
Kevin has made over 15 trades of the IQVIA Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 13,206 units of IQV stock worth $1,154,204 on 28 February 2024.
The largest trade he's ever made was selling 46,080 units of IQVIA Inc stock on 3 May 2019 worth over $6,361,805. On average, Kevin trades about 5,154 units every 70 days since 2016. As of 28 February 2024 he still owns at least 13,858 units of IQVIA Inc stock.
You can see the complete history of Mr. Knightly stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Kevin Knightly biography
Kevin C. Knightly serves as President - Information and Technology Solutions of the Company. Mr. Knightly served as Senior Vice President, Information Offerings at IMS Health from April 2015 to October 2016. From January 2011 to March 2015, Mr. Knightly served as Senior Vice President, Supplier Management at IMS Health. Prior to that, Mr. Knightly served in a number of senior financial, operations, marketing and general management roles for IMS Health, including as Senior Vice President, Pharma Business Management from 2007 until 2010. Mr. Knightly holds a B.S. in Economics and Accounting from the College of the Holy Cross, and an M.B.A. from New York University’s Stern Business School.
What is the salary of Kevin Knightly?
As the President - Information and Technology Solutions of IQVIA Inc, the total compensation of Kevin Knightly at IQVIA Inc is $2,613,750. There are 3 executives at IQVIA Inc getting paid more, with Ari Bousbib having the highest compensation of $22,139,800.
How old is Kevin Knightly?
Kevin Knightly is 59, he's been the President - Information and Technology Solutions of IQVIA Inc since 2016. There are 8 older and 9 younger executives at IQVIA Inc. The oldest executive at IQVIA Holdings Inc is Ronald Rittenmeyer, 72, who is the Independent Director.
What's Kevin Knightly's mailing address?
Kevin's mailing address filed with the SEC is C/O IQVIA HOLDINGS INC., 2400 ELLIS ROAD, DURHAM, NC, 27703.
Insiders trading at IQVIA Inc
Over the last 7 years, insiders at IQVIA Inc have traded over $7,012,312,980 worth of IQVIA Inc stock and bought 83,468 units worth $15,560,595 . The most active insiders traders include John Connaughton, Pension Plan Investment Boa... et Group Holdings (Sbs) Adviso.... On average, IQVIA Inc executives and independent directors trade stock every 29 days with the average trade being worth of $160,151,634. The most recent stock trade was executed by Eric Sherbet on 27 August 2024, trading 1,300 units of IQV stock currently worth $320,229.
What does IQVIA Inc do?
quintiles and imshealth have merged together to form the new quintilesims. each wanting to bring something new to customers, we deliver integrated information and technology solutions to drive healthcare forward. quintilesims has approximately 50,000 employees conducting operations in more than 100 countries, dedicated to helping our clients improve their clinical, scientific and commercial results. as a global leader in protecting individual patient privacy, quintilesims uses healthcare data to deliver critical, real-world disease and treatment insights. to learn more, visit www.quintilesims.com
What does IQVIA Inc's logo look like?
Complete history of Mr. Knightly stock trades at IQVIA Inc
IQVIA Inc executives and stock owners
IQVIA Inc executives and other stock owners filed with the SEC include:
-
Ari Bousbib,
Chairman of the Board, President, Chief Executive Officer -
Ari Bousbib,
Chairman, Pres & CEO -
Walter Staub,
President - Research and Development Solutions -
Kevin Knightly,
President - Information and Technology Solutions -
Eric Sherbet,
Executive Vice President, General Counsel, Secretary -
Ronald E. Bruehlman,
Exec. VP & CFO -
W. Richard Staub III,
Pres of R&D Solutions -
Eric M. Sherbet,
Exec. VP, Gen. Counsel & Sec. -
Kevin C. Knightly,
Pres of Technology & Commercial Solutions -
John Leonard,
Lead Independent Director -
Ronald Rittenmeyer,
Independent Director -
Colleen Goggins,
Independent Director -
John Danhakl,
Independent Director -
Carol Burt,
Independent Director -
Ronald Bruehlman,
Interim Chief Financial Officer, Executive Vice President -
Todd Sisitsky,
Independent Director -
James Fasano,
Independent Director -
John Connaughton,
Independent Director -
Trudy Stein,
Chief HR Officer & Exec. VP -
Nicholas Childs,
Sr. VP, Investor Relations & Corp. Communications -
Andrew Markwick,
Sr. VP of Investor Relations & Treasury -
Alejandro Martinez,
Chief Information Officer -
Dr. Jeffrey A. Spaeder,
Sr. VP, Global Chief Medical & Scientific Officer -
Emmanuel N. Korakis,
Sr. VP, Corp. Controller & Principal Accounting Officer -
Michael R Mcdonnell,
EVP and CFO -
W Richard Staub,
See Remarks -
Group Holdings (Sbs) Adviso...,
-
Investment Board Private Ho...,
-
Robert Parks,
Sr Vice President, Controller -
Michael J Evanisko,
Director -
Jack M Greenberg,
Director -
Iii James H Erlinger,
See Remarks -
Pension Plan Investment Boa...,
10% owner -
Pension Plan Investment Boa...,
-
Emmanuel N Korakis,
See Remarks -
Morris Leslie Wims,
Director -
Sheila A Stamps,
Director -
Bhavik Patel,
See Remarks -
Keriann Cherofsky,
See Remarks -
Constantinos Panagos,
See Remarks -
Jim Fasano,
Director